My Experience with Biotechs as a Financial Consultant for over a decade was the same for years. This was the case with a majority of all bio tech companies at various stages of their clinical research on several different products and all publicly OTC and Other exchange traded companies with various capitalization levels. Most of these companies traded year in year out reporting huge losses Net Net and yet they continued to trade well based always on expectations of future revenues.
Bottom Line on SVFC at half a penny PPS is that the Potential reward outweighs the .005 approximate risk per share. Of course. Risk tolerance and investment objectives are Personal.
I am holding all 15 Million shares Strong and looking at adding another 5 Million next week.
Good Luck to all SVFC Longs. No long discussions and analysis needed at this point. All is well. Dr. Victor is Expecting His shares to be worth much more in the short to medium term future and I am certain he will continue to convert any future debt by SVFC to him into SVFC shares and build his HUGE Personal Share Count.
News 
Market Data 
Discover 
